Microenvironment‐Responsive Nanomedicine Enables Vertical Modulation of Mitochondrial Pathological Networks in Myocardial Ischemia–Reperfusion Injury
Advanced Science · 2026-10 · 13 (55)
DOI: 10.1002/advs.76519 ↗At a glance
Journal article in Advanced Science, published online on 2026-07-13. Written by Jue Wang and 11 co-authors. Institution: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China. Major MEDLINE topics: Myocardial Reperfusion Injury, Nanomedicine, Mitochondria. Cited 1 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Central South University Research Programme of Advanced Interdisciplinary Studies, Key Research and Development Program of Hunan Province.
Abstract (original language)
Myocardial ischemia–reperfusion injury (MIRI) is a severe and largely unavoidable complication of reperfusion therapy and remains a major determinant of poor outcomes after acute myocardial infarction. Here, we developed a mitochondria‐targeted, ischemic microenvironment–responsive nanotherapeutic, termed Berberine/Isoliensinine‐loaded Melanin Nanocomposite (BIM), by co‐encapsulating the anti‐inflammatory agent berberine (BBR) and the anti‐apoptotic agent isoliensinine (ILS) within a melanin capsule with a controllable channel (MCC). Owing to its appropriate size, negative surface charge, and dual responsiveness to acidic pH and reactive oxygen species, BIM preferentially accumulates in injured myocardium and targets damaged mitochondria, enabling precise drug release at the pathological core. Through a structured pharmacological design, MCC scavenges mitochondrial reactive oxygen species, BBR suppresses inflammatory signaling, and ILS inhibits intrinsic apoptosis, together achieving vertical modulation of mitochondrial pathological networks. Consequently, BIM attenuates oxidative stress, limits inflammatory amplification, reduces cardiomyocyte apoptosis, and markedly decreases infarct size. These findings establish mitochondria‐centered vertical network modulation as a precise therapeutic strategy for MIRI.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
- Hunan Province International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Agents, Xiangya Hospital, Central South University, Changsha, China.
- Department of Pharmacy, Yizhang County People's Hospital, Chenzhou, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
- Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
ORCID profiles: Jue Wang, Qiong Huang
Funding
- National Natural Science Foundation of China
- Central South University Research Programme of Advanced Interdisciplinary Studies
- Key Research and Development Program of Hunan Province
- Project Program of National Clinical Research Center for Geriatric Disorders
- Nature Science Foundation of Hunan Province grant
- Hunan Provincial Natural Science Foundation Joint Fund for Medicine and Science
Cite
APA
Wang, J., Zhou, J., Yuan, W., Zhao, T., Huang, Y., Xia, Y., Lin, Y., Li, F., Huang, Q., Liu, C., Ai, K., & Qin, Q. (2026). Microenvironment‐Responsive Nanomedicine Enables Vertical Modulation of Mitochondrial Pathological Networks in Myocardial Ischemia–Reperfusion Injury. Advanced Science, 13(55). https://doi.org/10.1002/advs.76519
Vancouver
Wang J, Zhou J, Yuan W, Zhao T, Huang Y, Xia Y, et al. Microenvironment‐Responsive Nanomedicine Enables Vertical Modulation of Mitochondrial Pathological Networks in Myocardial Ischemia–Reperfusion Injury. Advanced Science. 2026;13(55). doi:10.1002/advs.76519
BibTeX
@article{Wang2026,
author = {Wang, Jue and Zhou, Jia and Yuan, Wenqin and Zhao, Tianjiao and Huang, Yunying and Xia, Yingci and Lin, Yuting and Li, Fei and Huang, Qiong and Liu, Chong and Ai, Kelong and Qin, Qun},
title = {Microenvironment‐Responsive Nanomedicine Enables Vertical Modulation of Mitochondrial Pathological Networks in Myocardial Ischemia–Reperfusion Injury},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {55},
doi = {10.1002/advs.76519}
}
EUVIMED